These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11193279)

  • 1. Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life.
    Cutts MW; Thomas AN; Kishen R
    Intensive Care Med; 2000 Nov; 26(11):1694-7. PubMed ID: 11193279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.
    Shum HP; Chan KC; Kwan MC; Yan WW
    Hong Kong Med J; 2013 Dec; 19(6):491-7. PubMed ID: 23650198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
    Salmon J; Cardigan R; Mackie I; Cohen SL; Machin S; Singer M
    Intensive Care Med; 1997 Jan; 23(1):38-43. PubMed ID: 9037638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell transfusion practices and the impact of phlebotomy in an adult intensive care unit in Trinidad--a prospective observational study.
    Bedayse N; Hariharan S; Chen D
    West Indian Med J; 2010 Jan; 59(1):67-72. PubMed ID: 20931917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study.
    Chant C; Wilson G; Friedrich JO
    Crit Care; 2006; 10(5):R140. PubMed ID: 17002795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood flow reductions during continuous renal replacement therapy and circuit life.
    Baldwin I; Bellomo R; Koch B
    Intensive Care Med; 2004 Nov; 30(11):2074-9. PubMed ID: 15448889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients.
    Baudouin SV; Wiggins J; Keogh BF; Morgan CJ; Evans TW
    Intensive Care Med; 1993; 19(5):290-3. PubMed ID: 8408939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
    Joannidis M; Kountchev J; Rauchenzauner M; Schusterschitz N; Ulmer H; Mayr A; Bellmann R
    Intensive Care Med; 2007 Sep; 33(9):1571-9. PubMed ID: 17563874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of blood transfusion in relation to ICU admission-a single centre audit.
    Ghosh AN; Green JV; Tobin A; Jones D; Duke GJ
    Anaesth Intensive Care; 2013 Nov; 41(6):788-92. PubMed ID: 24180721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLOOD TRANSFUSION IN CRITICALLY ILL PATIENTS IN AN INTENSIVE CARE UNIT OF A TERTIARY HOSPITAL IN NIGERIA.
    Tobi KU; Imarengiaye CO
    East Afr Med J; 2014 Dec; 91(12):435-41. PubMed ID: 26859011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient.
    Taylor RW; Manganaro L; O'Brien J; Trottier SJ; Parkar N; Veremakis C
    Crit Care Med; 2002 Oct; 30(10):2249-54. PubMed ID: 12394952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin clearance during continuous veno-venous haemofiltration.
    Singer M; McNally T; Screaton G; Mackie I; Machin S; Cohen SL
    Intensive Care Med; 1994; 20(3):212-5. PubMed ID: 8014289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood loss from diagnostic laboratory tests performed in intensive care units. Preliminary study].
    Alazia M; Colavolpe JC; Botti G; Corda N; Ramero C; François G
    Ann Fr Anesth Reanim; 1996; 15(7):1004-7. PubMed ID: 9180974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anemia, phlebotomy practices, and blood transfusion requirements in 45 critically ill cats (2009-2011).
    Balakrishnan A; Drobatz KJ; Reineke EL
    J Vet Emerg Crit Care (San Antonio); 2016 May; 26(3):406-11. PubMed ID: 26264778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion practice in critically ill patients: a single institutional experience.
    Al-Faris L; Al-Fares AR; Abdul Malek K; Omran A; Al-Humood S
    Med Princ Pract; 2012; 21(6):560-5. PubMed ID: 22653167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of patients readmitted to the intensive care unit.
    Durbin CG; Kopel RF
    Crit Care Med; 1993 Oct; 21(10):1547-53. PubMed ID: 8403966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death.
    Dunne JR; Malone DL; Tracy JK; Napolitano LM
    Surg Infect (Larchmt); 2004; 5(4):395-404. PubMed ID: 15744131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood usage in an Australian intensive care unit: have we met best practice goals?
    Farrar D; Robertson MS; Hogan CJ; Roy S; Boyce CA; Howe BD; Presneill JJ; Cade JF
    Anaesth Intensive Care; 2004 Dec; 32(6):775-80. PubMed ID: 15648987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.